Brief: Abeona Therapeutics Enters Into Agreement To Sell Priority Review Voucher
12/05/2025 12:32
May 12 (Reuters) - Abeona Therapeutics Inc ABEO.O: ABEONA THERAPEUTICS® ENTERS INTO AGREEMENT TO SELL PRIORITY REVIEW VOUCHER FOR $155 MILLION ABEONA THERAPEUTICS INC: ANTICIPATE BECOMING PROFITABLE IN EARLY 2026 Source text: ID:nGNXbtCF53 Further company coverage: ABEO.O
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports